A German blood test that measures how blood proteins change shape; the only studies are small, run with the inventor, and do not say how often it finds early cancers.
The Carcimun test detects conformational changes in plasma proteins through optical extinction. In a study of 172 people co-authored by the inventor (Walter et al., Frontiers in Oncology 2025: 80 healthy volunteers, 64 with cancers of various types, 28 with inflammatory conditions or benign tumours) it distinguished the groups with 90.6% sensitivity and 98.2% specificity. An earlier privately funded study (Salat et al., Precision Cancer Medicine 2022; 170 with cancer, 137 healthy) reported 88.8% sensitivity and 91.2% specificity and stated that details of the procedure could not be given because of patenting. No stage-by-stage figures, screening-population study, regulatory status, company details or price could be confirmed; the developer's website could not be reached on 29 October 2026.
Measures how plasma proteins change shape, read as optical extinction; the developers have not published the full procedure, citing patenting.
1.Carcimun test slips into a pocket on its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Carcimun test" OR ABSTRACT:"Carcimun test" OR TITLE:"Carcimun" OR ABSTRACT:"Carcimun") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Carcimun test, not a curated reading list.
Shares Proteomics & phosphoproteomics, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Proteomics & phosphoproteomics, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Proteomics & phosphoproteomics, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Proteomics & phosphoproteomics, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Proteomics & phosphoproteomics, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/